- Baudax Bio Inc (NASDAQ:BXRX) announced the outcome of its first interim analysis in a Phase 2 trial of BX1000 for neuromuscular blockade (NMB) in patients undergoing elective surgery.
- The trial evaluates three doses of BX1000 to a standard dose of rocuronium and expects to enroll 80 adult patients undergoing elective surgery utilizing total intravenous anesthesia.
- Additionally, the trial evaluates the safety and tolerability profile of BX1000 and rocuronium in this patient population.
- The pre-planned interim analysis evaluated the intubating conditions for each patient after administering the study drug in a blinded fashion.
- All 20 patients were observed to have met the criteria for Good or Excellent intubating conditions at 60 seconds. Nineteen of the subjects were successfully intubated following the assessment at 60 seconds, and the remaining subject followed the assessment at 90 seconds.
- Study treatments were generally well tolerated, with no severe or serious adverse events.
- The company plans to complete enrollment in the study in Q1 and share the topline results for the study in April 2023.
- Price Action: BXRX shares are up 39.40% at $4.39 on the last check Tuesday.
Why Baudax Bio Shares Trading Higher Today
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.